Pulmonary arterial hypertension due to antiphospholipid syndrome initially mimicking chronic thromboembolic pulmonary hypertension.
Jina YeoNami ShinKyung-Jin AhnMiryoung SeoAlbert Youngwoo JangMinsu KimWook-Jin ChungPublished in: Clinical hypertension (2022)
Pulmonary arterial hypertension (PAH) is the second most common lung complication in antiphospholipid syndrome (APS) patients. However, the concurrent development of APS-related nonthrombotic PAH is rarely reported. Lack of awareness for group 1 PAH in APS patient may contribute to underdiagnosis of this condition. Herein, we reviewed the case of a 56-year-old female who was diagnosed with PAH related to APS that mimicked chronic thromboembolic pulmonary hypertension (CTEPH). It is crucial to be aware of the possibility of a group 1 PAH diagnosis, even though patients have already been diagnosed with CTEPH. Furthermore, a multidisciplinary approach and serial follow-up right heart catheterization with echocardiography are important to make a timely diagnosis and provide optimal treatment for APS-related PAH in patients with CTEPH-like clinical features.
Keyphrases
- pulmonary arterial hypertension
- pulmonary hypertension
- pulmonary artery
- end stage renal disease
- ejection fraction
- newly diagnosed
- polycyclic aromatic hydrocarbons
- chronic kidney disease
- peritoneal dialysis
- heart failure
- computed tomography
- coronary artery
- patient reported outcomes
- case report
- quality improvement
- smoking cessation
- replacement therapy